ElevateBio
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
About ElevateBio
ElevateBio is an operator of a portfolio of cell and gene therapy companies intended to develop, manufacture, and commercialize life-transforming medicines. The company creates a portfolio through partnerships with the world's innovative scientists and inventors as well as it created a centralized facility that integrates all the elements that translate cell and gene therapy R&D into commercially viable therapies quickly and efficiently, enabling patients to get medical products to treat severe diseases. Vikas Sinha, Mitchell Finer, and David Hallal co-founded ElevateBio in Cambridge, Massachusetts in 2017.
Company Facts
- Headquarters
- Waltham
- Founded
- 2017
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00251_00500
- Funding Stage
- late_stage_venture
- Total Funding
- $1,246,000,000
- Last Funding Type
- series_d
- Last Funding Date
- 2023-05-24
- Website
- elevate.bio
Industries & Categories
Alternative Medicine, Biotechnology, Information Technology
Social Links
Canonical: https://fsome.com/organization/elevatebio-123966 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.